Description: Cyclopharm Limited is engaged in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development. The Company operates in two business segments: Technegas segment and Molecular imaging segment. The Technegas segment is a supplier of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. The Molecular Imaging segment produces radiopharmaceuticals used by physicians in the detection of cancer, neurological disorders and cardiac diseases. The Company offers Technegas for lung imaging, and Molecular Imaging/Positron Emission Tomography radiopharmaceuticals, which are used in cancer, brain and cardiac imaging. The Company formed a joint venture with Alfred Health Solutions and Macquarie University Hospital to provide various imaging services on-site at the hospital. The Company's Ultralute is a device that extends the useful life of Molybdenum-99 (Mo-99) generators.
Home Page: www.cyclopharm.com
CYC Technical Analysis
1 The Crescent
Kingsgrove,
NSW
2208
Australia
Phone:
61 2 9541 0411
Officers
| Name | Title |
|---|---|
| Mr. James S. McBrayer F.A.C.I.D., BSPharm, GDM, FAICD, AIM | CEO, MD, Company Sec. & Director |
| Mr. Mathew Farag | Chief Operating Officer |
| Mr. Graham N. Phillips | Fin. Mang. |
| Dr. Mark Doverty | Global Head of Regulatory Compliance & Clinical Research |
| Ms. Sally-Ann Cornelius | Head of Sales |
| Ms. Niamh McAree | Head of Quality and Regulatory |
| Mr. Chris Quinn | Head of Service |
| Ms. Sui Ling Cheah | Financial Controller |
| Mr. Lynn McLauchlin | Gen. Mang. of Canada |
| Mr. Gary T. Somerville | Quality & Regulatory Mang. |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 106.383 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.0314 |
| Price-to-Sales TTM: | 5.2757 |
| IPO Date: | 2007-01-19 |
| Fiscal Year End: | December |
| Full Time Employees: | 51 |